| Antibiotic use in eastern Europe: a cross-national database study in coordination with the WHO Regional Office for Europe A Versporten, G Bolokhovets, L Ghazaryan, V Abilova, G Pyshnik, ... The Lancet Infectious Diseases 14 (5), 381-387, 2014 | 417 | 2014 |
| The implementation of managed entry agreements in Central and Eastern Europe: findings and implications A Ferrario, D Arāja, T Bochenek, T Čatić, D Dankó, M Dimitrova, J Fürst, ... Pharmacoeconomics 35 (12), 1271-1285, 2017 | 164 | 2017 |
| Barriers for access to new medicines: searching for the balance between rising costs and limited budgets B Godman, A Bucsics, P Vella Bonanno, W Oortwijn, CC Rothe, A Ferrario, ... Frontiers in public health 6, 328, 2018 | 157 | 2018 |
| Ongoing strategies to improve the management of upper respiratory tract infections and reduce inappropriate antibiotic use particularly among lower and middle-income countries … B Godman, M Haque, J McKimm, M Abu Bakar, J Sneddon, J Wale, ... Current medical research and opinion 36 (2), 301-327, 2020 | 156 | 2020 |
| Systemic measures and legislative and organizational frameworks aimed at preventing or mitigating drug shortages in 28 European and Western Asian countries T Bochenek, V Abilova, A Alkan, B Asanin, I de Miguel Beriain, Z Besovic, ... Frontiers in pharmacology 8, 942, 2018 | 118 | 2018 |
| Provision of community pharmacy services during COVID-19 pandemic: a cross sectional study of community pharmacists’ experiences with preventative measures and sources of … K Hoti, A Jakupi, D Hetemi, D Raka, J Hughes, S Desselle International journal of clinical pharmacy 42 (4), 1197-1206, 2020 | 110 | 2020 |
| Fixed dose drug combinations–are they pharmacoeconomically sound? Findings and implications especially for lower-and middle-income countries B Godman, H McCabe, T D Leong, D Mueller, AP Martin, I Hoxha, ... Expert review of pharmacoeconomics & outcomes research 20 (1), 1-26, 2020 | 86 | 2020 |
| Potential approaches for the pricing of cancer medicines across Europe to enhance the sustainability of healthcare systems and the implications B Godman, A Hill, S Simoens, G Selke, I Selke Krulichová, ... Expert review of pharmacoeconomics & outcomes research, 1-14, 2021 | 68 | 2021 |
| The expiry of Humira® market exclusivity and the entry of adalimumab biosimilars in Europe: An overview of pricing and national policy measures E Moorkens, B Godman, I Huys, I Hoxha, A Malaj, S Keuerleber, ... Frontiers in pharmacology 11, 1993, 2021 | 68 | 2021 |
| Market exclusivity and the entry of adalimumab biosimilars in Europe: an overview of pricing and national policy measures E Moorkens, B Godman, I Huys, I Hoxha, A Malaj, S Keuerleber, ... Frontiers Research Foundation, 2021 | 68 | 2021 |
| Antimicrobial medicines consumption in Eastern Europeand Central Asia–an updated cross-national study and assessment of quantitativemetrics for policy action J Robertson, K Iwamoto, I Hoxha, L Ghazaryan, V Abilova, A Cvijanovic, ... Frontiers in pharmacology 9, 1156, 2019 | 61 | 2019 |
| Tuberculosis treatment adherence of patients in Kosovo S Krasniqi, A Jakupi, A Daci, B Tigani, N Jupolli-Krasniqi, M Pira, V Zhjeqi, ... Tuberculosis research and treatment 2017, 2017 | 54 | 2017 |
| Pricing of oral generic cancer medicines in 25 European countries; findings and implications B Godman, A Hill, S Simoens, A Kurdi, J Gulbinovič, A Martin, A Timoney, ... Generics and Biosimilars Initiative Journal 8 (2), 49-70, 2019 | 52 | 2019 |
| Proposal for a regulation on health technology assessment in Europe–opinions of policy makers, payers and academics from the field of HTA P Vella Bonanno, A Bucsics, S Simoens, AP Martin, W Oortwijn, ... Expert review of pharmacoeconomics & outcomes research 19 (3), 251-261, 2019 | 46 | 2019 |
| Cardiac arrest–cardiopulmonary resuscitation B Lenjani, N Baftiu, K Pallaska, K Hyseni, N Gashi, N Karemani, I Bunjaku, ... Journal of Acute Disease 3 (1), 31-35, 2014 | 39 | 2014 |
| The Current Situation Regarding Long-Acting Insulin Analogues Including Biosimilars Among African, Asian, European, and South American Countries; Findings and Implications for … B Godman, M Haque, T Leong, E Allocati, S Kumar, S Islam, J Charan, ... Frontiers in Public Health 9, 636, 2021 | 37 | 2021 |
| Culture of antibiotic use in Kosovo-an interview study with patients and health professionals A Jakupi, D Raka, S Kaae, SK Sporrong Pharmacy Practice (Granada) 17 (3), 2019 | 24 | 2019 |
| Utilization and expenditure of anti-cancer medicines in Kosovo: findings and implications A Jakupi, B Godman, A Martin, A Haycox, I Baholli PharmacoEconomics-open 2 (4), 423-432, 2018 | 21 | 2018 |
| Experiences from a pilot study on how to conduct a qualitative multi-country research project regarding use of antibiotics in Southeast Europe S Kaae, SK Sporrong, JM Traulsen, HW Kildemoes, LS Nørgaard, ... Journal of Pharmaceutical Policy and Practice 9 (20), 2016 | 19 | 2016 |
| Antibiotic utilisation in adult and children patients in Kosovo hospitals S Krasniqi, A Versporten, A Jakupi, D Raka, A Daci, V Krasniqi, Z Deva, ... European Journal of Hospital Pharmacy 26 (3), 146-151, 2019 | 9 | 2019 |
Lul RakaUniversity of PrishtinaVerified email at uni-pr.edu
